PortfoliosLab logo

Acumen Pharmaceuticals, Inc. (ABOS)

Equity · Currency in USD · Last updated Oct 1, 2022

Company Info

ISINUS00509G2093
CUSIP00509G209
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.77
Year Range$3.08 - $16.14
EMA (50)$5.44
EMA (200)$6.81
Average Volume$44.37K
Market Capitalization$193.20M

ABOSShare Price Chart


Chart placeholderClick Calculate to get results

ABOSPerformance

The chart shows the growth of $10,000 invested in Acumen Pharmaceuticals, Inc. in Jul 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,990 for a total return of roughly -50.10%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%MayJuneJulyAugustSeptember
145.21%
-21.76%
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ABOSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M91.05%-10.05%
6M156.52%-20.85%
YTD48.37%-24.77%
1Y-32.46%-17.75%
5Y-42.66%-13.85%
10Y-42.66%-13.85%

ABOSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-24.26%14.45%-33.28%-1.28%-8.29%32.77%15.74%4.60%76.27%
2021-22.99%15.76%-17.08%-5.45%-43.77%-14.43%

ABOSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acumen Pharmaceuticals, Inc. Sharpe ratio is -0.25. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20Jul 10Jul 17Jul 24Jul 31Aug 07Aug 14Aug 21Aug 28Sep 04Sep 11Sep 18Sep 25
-0.25
-0.77
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ABOSDividend History


Acumen Pharmaceuticals, Inc. doesn't pay dividends

ABOSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-50.54%
-25.25%
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ABOSWorst Drawdowns

The table below shows the maximum drawdowns of the Acumen Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acumen Pharmaceuticals, Inc. is 84.81%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.81%Jul 6, 2021216May 11, 2022

ABOSVolatility Chart

Current Acumen Pharmaceuticals, Inc. volatility is 389.10%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%MayJuneJulyAugustSeptember
389.10%
19.40%
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)